Altamira Therapeutics Ltd. Adjustments For Decrease Increase In Prepaid Expenses
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Decrease Increase In Prepaid Expenses of $161.31 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2025-08-29
- 2025-06-30: Adjustments For Decrease Increase In Prepaid Expenses 6 month $161.31K.
- 2024-06-30: Adjustments For Decrease Increase In Prepaid Expenses 6 month $255.45K.
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 6 month |
|---|---|
| 2025-06-30 | $161.31K 6-K · filed 2025-08-29 |
| 2024-06-30 | $255.45K 6-K · filed 2025-08-29 |